Brief: Viatris Q1 Adjusted EPS USD 0.59 Vs. IBES Estimate USD 0.5
07/05/2026 11:59
May 07 (Reuters) - Viatris Q1 revenue USD 3,517 million vs. IBES estimate USD 3,357 million. Q1 EPS USD 0.15 outlook FY revenue USD 14,450-14,950 million vs. IBES estimate USD 14,638 million outlook FY adjusted EPS USD 2.33-2.47 vs. IBES estimate USD 2.44
Recent news on Viatris
See all newsBrief: Viatris Receives U.S. FDA Approval For Ryzumvi® For The Treatment Of Presbyopia
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Deals of the day-Mergers and acquisitions
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal